ROK Options Traders Turn Defensive After Sharp Tuesday Drop

Rockwell Automation heads into the week with options positioning flashing the most defensive signal in months, just as the stock logged its steepest single-day decline since early spring.

The clearest standout is in options. The put/call ratio jumped to 0.79 on Tuesday — more than three standard deviations above its 20-day mean of 0.59, the highest z-score reading in the data window. That is a sharp and sudden shift: the PCR had been running in a tight band between 0.51 and 0.66 for most of the prior six weeks before spiking abruptly. The move points to a meaningful increase in demand for downside protection, and it coincided with a 4.5% single-session decline that took the stock to $456.36, trimming the one-week return to -2.1%.

Short interest tells a quieter story and does not add meaningfully to the bearish case. At 3.1% of the free float, the position is modest by any standard. It has edged higher — up roughly 2.9% over the past week — but the absolute level remains low. Borrow conditions are loose: availability is running at around 1,540%, meaning there are roughly 15 shares available to lend for every one already borrowed. Cost to borrow is near its 30-day low at 0.37%, down from a peak above 0.53% in early June. The lending market is not generating pressure in either direction.

The Street's posture is cautious but not outright negative. The consensus sits at "hold" across 15 analysts, with a mean price target of $465 — a narrow 2% premium to Tuesday's close. The most recent formal action came from DA Davidson on June 16, initiating with Neutral and a $500 target. Before that, a cluster of upgrades following the May earnings print pushed targets higher from multiple firms, including Barclays lifting to $480 and Citigroup moving to $500, both maintaining positive ratings. JP Morgan's Stephen Tusa kept his Neutral, raising to $417 — a target that now sits well below the current price, suggesting the cautious wing of the Street has less conviction in the recovery. The bull case rests on margin expansion: management guided FY25 segment margins toward 20% with over $250 million in cost reductions, and non-GAAP EPS guidance was raised to $9.20–$10.20. Bears focus on revenue, which fell 4% year-over-year across all three segments, with a further 2% decline projected in 2025. The PE ratio is running at roughly 34.6x, the PB at 13x — valuations that leave little margin for error on the cost-out thesis.

The earnings history adds relevant context. The most recent print on May 5 produced a 14.7% single-day gain and a 13.7% five-day gain — a large positive reaction that explains much of the recovery from the April lows. Before that, the February result generated a more modest 2.9% one-day move. The next print is scheduled for August 4. ROK's closest peers were also hit hard Tuesday: EMR fell 4.7%, AME dropped 3.1%, and NVT led declines at -8.7%, suggesting the Tuesday selling was sector-wide rather than ROK-specific. Whether that read — broad industrial weakness rather than company-specific deterioration — holds up into the August earnings report is the central question for the weeks ahead.